Forensic Analysis · Industrials / Manufacturing / Defense · as of Aug 12, 2026

Hyster-Yale, Inc. (HY)

A forensic read on Hyster-Yale, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution

Forensic grade

Grey Zone

Financial health

1.9

Distress distance

Clean

Earnings quality

Forensic signals

-5.7

P / E (ttm)

-12.7%

ROE

$619M

Market cap

3.95%

Dividend yield

-12.5%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Hyster-Yale, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 1.9, placing it in the Grey zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-1.4%

FY2025

Return on invested capital. Return on invested capital is -1.4% in the latest fiscal year and rising from -3% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.

+1.5%/yr

FY2022–FY2025

Share-count dilution. Diluted share count changed +5% over the last 3 years to FY2025 (+1.5%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~1.5% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~4%.

$56M

FY2021–FY2021

Goodwill impairments. Took $56M of goodwill writedowns across 1 year (FY2021 ($56M)). Writedowns mean past acquisitions underperformed what was paid for them.

-56%

FY2012→FY2013

Dividend — cut. The payout was CUT ~56% in FY2013 (from FY2012) and hasn't been restored since. It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies.

Key fundamentals

Latest Revenue$3.77B

Revenue Growth YoY-12.5%

Revenue CAGR (3yr)+2.0%

Net Margin-1.6%

Free Cash Flow$23.6M

Return on Equity-12.7%

Debt / Equity1.05x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Hyster-Yale, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 12, 2026. Forensic signals flag probability, not certainty.